- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05030961
Team-based Virtual Pediatric Cochlear Implant Clinic
June 1, 2023 updated by: Chrisanda Sanchez, University of Miami
Implementation of a Team-based Virtual Clinic for Pediatric Cochlear Implants
The purpose of this study is to see if remote visits for pediatric cochlear implant patients are possible.
The investigator will be assessing whether a multi-disciplinary team approach can be achieved remotely for patients both undergoing the cochlear implant (CI) process and for those who have already been implanted.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christina Sarangoulis
- Phone Number: 305-243-8397
- Email: cmd247@med.miami.edu
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 12 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
New patients undergoing CI evaluation:
- English speaking patients (parents can speak English and/or Spanish)
- Ages 0-12 years who are cochlear implant candidates and undergoing the evaluation process
Established CI recipients:
- English speaking patients (parents can speak English and/or Spanish)
- Ages 1-12 with at least 6 months of CI experience with a company that has remote programming capacity
Exclusion Criteria:
- Patients with families who speak languages other than English or Spanish
- Patients who do not live in Florida
- Patients who have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pediatric Cochlear Implant Candidate Group
Participants who are in the process of receiving standard of care cochlear implant evaluation.
Participants will receive a virtual team-based clinic as a part of the candidacy evaluation process for one year.
|
Virtual team-based clinic will include consultation, counseling, and education from pediatric audiology, psychology, auditory verbal therapy, and education.
Each session lasts approximately 30 minutes with a total of 3 sessions within the year.
|
Experimental: Established Cochlear Implant Recipient Group
Participants who are established cochlear implant recipients.
Participants will receive a virtual team-based clinic, including remote cochlear implant programming, for one year.
|
Virtual team-based clinic will include consultation, counseling, and education from pediatric audiology, psychology, auditory verbal therapy, and education.
Each session lasts approximately 30 minutes with a total of 3 sessions within the year.
Remote cochlear implant programming will be provided via Zoom on a study-provided encrypted laptop.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Electrode Impedances
Time Frame: Up to 1 year
|
Electrode Impedances values, reported in kOhm, will be extracted from the cochlear implant software
|
Up to 1 year
|
Electrically evoked compound potential values
Time Frame: Up to 1 year
|
Electrically evoked compound potential values, reported in mV, will be extracted from the cochlear implant software
|
Up to 1 year
|
Datalogging
Time Frame: Up to 1 year
|
Datalogging, reported in hours per week, will be extracted from the cochlear implant software
|
Up to 1 year
|
Threshold/Upper stimulation levels
Time Frame: Up to 1 year
|
As measured from the cochlear implant software
|
Up to 1 year
|
LittleEars questionnaire scores
Time Frame: Up to 1 year
|
The LittleEars auditory questionnaire (LEAQ) uses parent responses to assess auditory behavior in children up to 24 months of age.
The questionnaire is scored from 0 to 35 with 0 indicating poorer performance and 35 indicating better performance.
|
Up to 1 year
|
Auditory Skills Checklist (ASC) scores
Time Frame: Up to 1 year
|
ASC has a Total Score ranges from zero to 70, with higher scores indicating development of increasingly complex listening skills
|
Up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavior Assessment System for Children version 3 (BASC-3) scores
Time Frame: Up to 1 year
|
BASC-3 is scored 0-120 as a T score.
Any scores between 60-70 is considered at risk / requires monitoring and scores greater than 70 are considered clinically significant / an area that likely requires therapeutic intervention.
|
Up to 1 year
|
Patient Health Questionnaire version 8 (PHQ-8) scores
Time Frame: Up to 1 year
|
PHQ-8 has 8 items rated on a scale from "not at all" (0) to "nearly every day" (3), with higher scores indicating greater frequency of depressive symptoms.
The sum of the items indicates the overall level of depressive symptoms indicating mild (5-9), moderate (10-14), moderately severe (15-19), and severe depressive symptoms (20- 24).
|
Up to 1 year
|
Generalized Anxiety Disorder version 7 (GAD-7) scores
Time Frame: Up to 1 year
|
GAD-7 is a 7-item self-report questionnaire of anxiety symptomatology in the past 14 days.
Respondents rate the frequency of each item during the past two weeks on a 0-3-point scale ranging from not at all (0) to nearly every day (3).
The sum of the items indicates the overall level of anxiety symptoms indicating mild (0-4), moderate (5-9), moderately severe (10-14), and severe (15- 21).
|
Up to 1 year
|
Quality of Life- CI (QoL-CI) scores
Time Frame: Up to 1 year
|
QoL-CI is scored 0-100 with higher scores indicating better quality of life.
|
Up to 1 year
|
Cochlear Implant Quality of Life-35 Profile (CIQOL-35 Profile) scores
Time Frame: Up to 1 year
|
CIQOL-35 Profile is a 35 item questionnaire with a total score ranging from 0-100% with a higher score indicating a higher level of functional ability with a cochlear implant
|
Up to 1 year
|
Parenting Stress Index/Short Form (PSI) scores
Time Frame: Up to 1 year
|
Parenting Stress Index/Short Form (PSI) contains 36 items rated on a 6-point Likert scale (1 = Strongly Disagree to 5 = Strongly Agree) and a total score.
Higher scores indicate increased parenting stress.
|
Up to 1 year
|
Parenting Stress-CI scores
Time Frame: Up to 1 year
|
Parenting Stress-CI is completed by the parent and scored from "not at all stressful" (0) to "very stressful" (3) with higher scores indicating greater degrees of parenting stress.
For parents of children 0-5 years, there are 15 items.
For parents of children 6-12 years there are 8 items.
|
Up to 1 year
|
Scale of Parental Involvement and Self-Efficacy-Revised (SPISE-R) scores
Time Frame: Up to 1 year
|
The SPISE-R is comprised of 46 questions that uses a 7-point Likert scale to query parents' beliefs, knowledge, confidence, and actions relevant to supporting their child's auditory access and spoken language development.
The total average score will range from 1 to 7 with 7 indicating the highest score / highest level of parental involvement and self efficacy.
|
Up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Chrisanda M Sanchez, AuD, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2021
Primary Completion (Actual)
June 1, 2023
Study Completion (Actual)
June 1, 2023
Study Registration Dates
First Submitted
August 19, 2021
First Submitted That Met QC Criteria
August 26, 2021
First Posted (Actual)
September 1, 2021
Study Record Updates
Last Update Posted (Actual)
June 2, 2023
Last Update Submitted That Met QC Criteria
June 1, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210584
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
Clinical Trials on Virtual team-based clinic
-
Harvard Medical School (HMS and HSDM)Massachusetts General HospitalActive, not recruitingBurnout, Professional | Burnout, Student | Exercise | Community Building | MentorshipUnited States
-
Bhumirajanagarindra Kidney Institute, ThailandMinistry of Health, ThailandCompletedDiabetic Nephropathy | Chronic Kidney DiseaseThailand
-
National University Hospital, SingaporeCompleted
-
University of Colorado, DenverThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType 1 DiabetesUnited States
-
Emory UniversityGeorgia Center for Diabetes Translation ResearchRecruiting
-
Children's Hospital Los AngelesUniversity of Southern California; Cedars-Sinai Medical CenterActive, not recruiting
-
Jaeb Center for Health ResearchCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
Shaukat Khanum Memorial Cancer Hospital & Research...Enrolling by invitationSatisfaction, Patient | SatisfactionPakistan
-
Abbott Medical DevicesActive, not recruitingParkinson DiseaseUnited States, Spain, Germany, United Kingdom
-
Connolly Hospital BlanchardstownCompletedOutpatients General Surgery Virtual ClinicIreland